Other formats:
BibTeX
LaTeX
RIS
@article{1398270,
author = {Kobyliak, N. and Virchenko, O. and Falalyeyeva, T. and Kondro, M. and Beregova, T. and Bodnar, P. and Shcherbakov, O. and Bubnov, R. and Caprnda, M. and Delev, D. and Sabo, J. and Kružliak, Peter and Rodrigo, L. and Opatrilova, R. and Spivak, M.},
article_location = {PARIS},
article_number = {JUN 2017},
doi = {http://dx.doi.org/10.1016/j.biopha.2017.03.099},
keywords = {Obesity; Non-alcoholic fatty liver disease (NAFLD); Inflammation; Cytokines; Nanocrystalline cerum dioxide},
language = {eng},
issn = {0753-3322},
journal = {BIOMEDICINE & PHARMACOTHERAPY},
title = {Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats},
volume = {90},
year = {2017}
}
TY - JOUR
ID - 1398270
AU - Kobyliak, N. - Virchenko, O. - Falalyeyeva, T. - Kondro, M. - Beregova, T. - Bodnar, P. - Shcherbakov, O. - Bubnov, R. - Caprnda, M. - Delev, D. - Sabo, J. - Kružliak, Peter - Rodrigo, L. - Opatrilova, R. - Spivak, M.
PY - 2017
TI - Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
JF - BIOMEDICINE & PHARMACOTHERAPY
VL - 90
IS - JUN 2017
SP - 608-614
EP - 608-614
PB - ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
SN - 07533322
KW - Obesity
KW - Non-alcoholic fatty liver disease (NAFLD)
KW - Inflammation
KW - Cytokines
KW - Nanocrystalline cerum dioxide
N2 - Background: Obesity is a risk factor for non-alcoholic fatty liver disease (NAFLD). The disease is associated with impairment of pro/antioxidant equilibrium and the inflammation in liver tissue. The aim of the work was to investigate the anti-inflammatory properties of the nanocrystalline cerium dioxide (nCeO(2)) on the rat model of NAFLD associated with monosodium glutamate (MSG)-induced obesity. Methods: The study was carried out on three groups of rats: control, MSG- and MSG + nCeO(2). They were injected with saline (control) or MSG. A month after born MSG- rats had been treated with water in a volume of 2.9 ml/kg, MSG + CeO2 groups - with CeO2 intragastrically (i.g.). The anthropometric and carbohydrate metabolism parameters, content of proinflammatory cytokines (interleukin (IL)-1 beta, IL-12Bp40, interferon-gamma (INF-gamma)) and anti-inflammatory cytokines (IL-4, IL-10, tumor growth factor-beta (TGF-beta)) were measured by ELISA. Results: We have demonstrated the anti- obesity effect of nanocrystalline cerium dioxide and for the first time its anti- inflammatory properties. Nanoparticles reduced the content of pro-inflammatory cytokines (IL-1 beta, IL-12Bp40) in rat serum and restored the level of anti- inflammatory cytokines (IL-4, IL-10, TGF-beta) to the control values. Conclusion: The precise mechanisms of this phenomenon remain to be unclear but we suppose they are at least partially associated with the strong anti- oxidant action of studied substance. Nanocrystalline cerium dioxide attenuates the inflammatory processes in rat blood that can prevent obesity complications and liver injury. (C) 2017 Elsevier Masson SAS. All rights reserved.
ER -
KOBYLIAK, N., O. VIRCHENKO, T. FALALYEYEVA, M. KONDRO, T. BEREGOVA, P. BODNAR, O. SHCHERBAKOV, R. BUBNOV, M. CAPRNDA, D. DELEV, J. SABO, Peter KRUŽLIAK, L. RODRIGO, R. OPATRILOVA and M. SPIVAK. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. \textit{BIOMEDICINE \&{}amp; PHARMACOTHERAPY}. PARIS: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2017, vol.~90, JUN 2017, p.~608-614. ISSN~0753-3322. Available from: https://dx.doi.org/10.1016/j.biopha.2017.03.099.
|
